SUMMARY For the early diagnosis of herpes simplex encephalitis IgG and IgM antibodies to herpes simplex virus in cerebrospinal fluid were measured by an enzyme linked immunosorbent assay (ELISA) and a local production index was calculated. Using these three criteria, 31 cases of various neurological illnesses were analysed. All eight cases of herpes simplex encephalitis were diagnosed correctly in the acute phase, and there were no false positive results.
The prognosis of herpes simplex encephalitis has been improved since the introduction of antiviral agents such as acyclovir and vidarabine.1 Early diagnosis is therefore important. Although detection of herpes simplex virus antigen in a brain biopsy specimen is one of the most reliable methods of early diagnosis this is not always possible because of the risk of side effects. We have previously investigated the intrathecal synthesis of antibodies in mumps meningitis, and have shown that the ratio of antibodies in cerebrospinal fluid to that in serum (C:S ratio) was moderately increased by the intrathecal synthesis of antimumps antibodies. 2 Levine et at3 reported that the C:S ratio of antibodies against herpes simplex virus was more than 1:20 in herpes simplex encephalitis, and that the amount of local production of antibodies could indicate the diagnosis early. In some neurological disorders, however, the serum can escape into cerebrospinal fluid across the damaged blood brain barrier, and this could lead to misdiagnosis of herpes simplex encephalitis. As Antibody activities against herpes simplex virus were examined by ELISA using a modification of the method described by Sakata et group.bmj.com on November 6, 2017 -Published by http://adc.bmj.com/ Downloaded from in cerebrospinal fluid cells,6 and detection of an early herpes simplex virus antigen in the cerebrospinal fluid may have a limited use.7 Many reports3 have shown that high titres of antibodies to herpes simplex virus in cerebrospinal fluid is characteristic of herpes simplex encephalitis, and measurement of these titres could be useful for the early diagnosis of herpes simplex encephalitis. It is important, however, to distinguish between the local production of antibodies to herpes simplex virus and those produced in the serum that cross the damaged blood brain barrier. To clarify this point, we calculated the local production index, which was based on the correction of antibody against control virus by the C:S ratio.
Klapper et al8 reported that out of 10 patients with herpes simplex encephalitis tested within 10 days of the onset of their neurological illnesses, five had positive diagnostic indices by radioimmunoassay. Using our method, all patients with herpes simplex encephalitis could be diagnosed within 10 days of onset, and there were no false positive results. The mean time required for the diagnosis in our study was 6-7 days from the onset of herpes simplex encephalitis, which was shorter than in their report. It took only a few hours to measure antibodies by ELISA, so it might be more useful for rapid early diagnosis than the radioimmunoassay because of the simplicity of the methods.
In our study no patient without IgG antibodies to herpes simplex virus in the cerebrospinal fluid had herpes simplex encephalitis, but all patients who had IgM antibodies to herpes simplex virus in the cerebrospinal fluid had herpes simplex encephalitis. Patients who did not have IgM antibodies but did have IgG antibodies to herpes simplex virus could not be excluded from the herpes simplex encephalitis group on those criteria alone. They could, however, be diagnosed by using the third criterion; when the local production index was positive, they had herpes simplex encephalitis and when it was not, they did not. All 31 cases were diagnosed using this method in the acute phase. The sensitivities and specificities of our results were 100% (8 of 8) for herpes simplex encephalitis and 78-3% (18 of 23) for those that did not have herpes simplex encephalitis using the first criterion; 87-5% (7 of 8) and 100% (23 or 23) using the second criterion; and 50% (4 of 8) and 100% (23 of 23) using the third criterion. These figures improved to 100% (8 of 8) and 100% (23 of 23) when the criteria were combined. Both sensitivity and specificity improved remarkably when the third criterion was incorporated.
Kahlon et a19 showed recently the intrathecal synthesis of antibody against the viral structural protein of herpes simplex virus in herpes simplex encephalitis by the immunoblotting method. They reported that antibodies in cerebrospinal fluid against the glycoprotein B in herpes simplex virus rose sooner than antibodies to the other viral proteins, probably because of the high immunogenicity of glycoprotein B. It might be possible to improve the sensitivity for detection of antibodies to herpes simplex virus by using purified glycoprotein B as an antigen.
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